331 related articles for article (PubMed ID: 27230303)
1. Isoniazid-induced control of Mycobacterium tuberculosis by primary human cells requires interleukin-1 receptor and tumor necrosis factor.
Yamashiro LH; Eto C; Soncini M; Horewicz V; Garcia M; Schlindwein AD; Grisard EC; Rovaris DB; Báfica A
Eur J Immunol; 2016 Aug; 46(8):1936-47. PubMed ID: 27230303
[TBL] [Abstract][Full Text] [Related]
2. Isoniazid and host immune system interactions: A proposal for a novel comprehensive mode of action.
Khan SR; Manialawy Y; Siraki AG
Br J Pharmacol; 2019 Dec; 176(24):4599-4608. PubMed ID: 31517993
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs.
Subbian S; Tsenova L; O'Brien P; Yang G; Koo MS; Peixoto B; Fallows D; Dartois V; Muller G; Kaplan G
PLoS Pathog; 2011 Sep; 7(9):e1002262. PubMed ID: 21949656
[TBL] [Abstract][Full Text] [Related]
4. Dormant Mycobacterium tuberculosis converts isoniazid to the active drug in a Wayne's model of dormancy.
Raghunandanan S; Jose L; Kumar RA
J Antibiot (Tokyo); 2018 Nov; 71(11):939-949. PubMed ID: 30185901
[TBL] [Abstract][Full Text] [Related]
5. A virtual screen discovers novel, fragment-sized inhibitors of Mycobacterium tuberculosis InhA.
Perryman AL; Yu W; Wang X; Ekins S; Forli S; Li SG; Freundlich JS; Tonge PJ; Olson AJ
J Chem Inf Model; 2015 Mar; 55(3):645-59. PubMed ID: 25636146
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes.
Howard NC; Marin ND; Ahmed M; Rosa BA; Martin J; Bambouskova M; Sergushichev A; Loginicheva E; Kurepina N; Rangel-Moreno J; Chen L; Kreiswirth BN; Klein RS; Balada-Llasat JM; Torrelles JB; Amarasinghe GK; Mitreva M; Artyomov MN; Hsu FF; Mathema B; Khader SA
Nat Microbiol; 2018 Oct; 3(10):1099-1108. PubMed ID: 30224802
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis.
Ando H; Kitao T; Miyoshi-Akiyama T; Kato S; Mori T; Kirikae T
Mol Microbiol; 2011 Mar; 79(6):1615-28. PubMed ID: 21244531
[TBL] [Abstract][Full Text] [Related]
8. A silent mutation in mabA confers isoniazid resistance on Mycobacterium tuberculosis.
Ando H; Miyoshi-Akiyama T; Watanabe S; Kirikae T
Mol Microbiol; 2014 Feb; 91(3):538-47. PubMed ID: 24354762
[TBL] [Abstract][Full Text] [Related]
9. Impact of isoniazid resistance on virulence of global and south Indian clinical isolates of Mycobacterium tuberculosis.
Ameeruddin NU; Luke Elizabeth H
Tuberculosis (Edinb); 2014 Dec; 94(6):557-63. PubMed ID: 25270728
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of point mutation detection in Mycobacterium tuberculosis with isoniazid resistance using real-time PCR and TaqMan probe assay.
Riahi F; Derakhshan M; Mosavat A; Soleimanpour S; Rezaee SA
Appl Biochem Biotechnol; 2015 Mar; 175(5):2447-55. PubMed ID: 25503088
[TBL] [Abstract][Full Text] [Related]
11. Chemical disarming of isoniazid resistance in
Flentie K; Harrison GA; Tükenmez H; Livny J; Good JAD; Sarkar S; Zhu DX; Kinsella RL; Weiss LA; Solomon SD; Schene ME; Hansen MR; Cairns AG; Kulén M; Wixe T; Lindgren AEG; Chorell E; Bengtsson C; Krishnan KS; Hultgren SJ; Larsson C; Almqvist F; Stallings CL
Proc Natl Acad Sci U S A; 2019 May; 116(21):10510-10517. PubMed ID: 31061116
[No Abstract] [Full Text] [Related]
12. Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis.
Ando H; Kondo Y; Suetake T; Toyota E; Kato S; Mori T; Kirikae T
Antimicrob Agents Chemother; 2010 May; 54(5):1793-9. PubMed ID: 20211896
[TBL] [Abstract][Full Text] [Related]
13. Isoniazid derivatives and their anti-tubercular activity.
Hu YQ; Zhang S; Zhao F; Gao C; Feng LS; Lv ZS; Xu Z; Wu X
Eur J Med Chem; 2017 Jun; 133():255-267. PubMed ID: 28390957
[TBL] [Abstract][Full Text] [Related]
14. The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.
Tseng ST; Tai CH; Li CR; Lin CF; Shi ZY
J Microbiol Immunol Infect; 2015 Jun; 48(3):249-55. PubMed ID: 24184004
[TBL] [Abstract][Full Text] [Related]
15. Antitubercular activity of Ru (II) isoniazid complexes.
Aguiar Id; Tavares A; Roveda AC; da Silva AC; Marino LB; Lopes ÉO; Pavan FR; Lopes LG; Franco DW
Eur J Pharm Sci; 2015 Apr; 70():45-54. PubMed ID: 25638418
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates from Xi'an, China.
Zhou A; Nawaz M; Duan Y; Moore JE; Millar BC; Xu J; Yao Y
Microb Drug Resist; 2011 Jun; 17(2):275-81. PubMed ID: 21388297
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle encapsulated lipopeptide conjugate of antitubercular drug isoniazid: in vitro intracellular activity and in vivo efficacy in a Guinea pig model of tuberculosis.
Horváti K; Bacsa B; Kiss E; Gyulai G; Fodor K; Balka G; Rusvai M; Szabó E; Hudecz F; Bősze S
Bioconjug Chem; 2014 Dec; 25(12):2260-8. PubMed ID: 25394206
[TBL] [Abstract][Full Text] [Related]
18. Antituberculous drugs modulate bacterial phagolysosome avoidance and autophagy in Mycobacterium tuberculosis-infected macrophages.
Genestet C; Bernard-Barret F; Hodille E; Ginevra C; Ader F; Goutelle S; Lina G; Dumitrescu O;
Tuberculosis (Edinb); 2018 Jul; 111():67-70. PubMed ID: 30029917
[TBL] [Abstract][Full Text] [Related]
19. Chloroquine enhances the antimycobacterial activity of isoniazid and pyrazinamide by reversing inflammation-induced macrophage efflux.
Matt U; Selchow P; Dal Molin M; Strommer S; Sharif O; Schilcher K; Andreoni F; Stenzinger A; Zinkernagel AS; Zeitlinger M; Sander P; Nemeth J
Int J Antimicrob Agents; 2017 Jul; 50(1):55-62. PubMed ID: 28506804
[TBL] [Abstract][Full Text] [Related]
20. The susceptibility of Mycobacterium tuberculosis to isoniazid and the Arg-->Leu mutation at codon 463 of katG are not associated.
van Doorn HR; Kuijper EJ; van der Ende A; Welten AG; van Soolingen D; de Haas PE; Dankert J
J Clin Microbiol; 2001 Apr; 39(4):1591-4. PubMed ID: 11283093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
